Skip to main content

What the FDA labels say about taking them together

Doxazosin and nifedipine

Nifedipine's FDA label of December 24, 2024 names doxazosin in its drug interactions section; the doxazosin labels PlainMeds reads (2) do not name nifedipine. The nifedipine label: “Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively.”

Check it at the source: the doxazosin FDA label on DailyMed (effective October 15, 2023, Viatris Specialty LLC); the nifedipine FDA label on DailyMed (effective December 24, 2024, Aurobindo Pharma Limited).

What does the doxazosin label say about nifedipine?

Doxazosin's label (effective October 15, 2023) and its 1 other brand-application label do not name nifedipine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Cardura), Viatris Specialty LLC, effective October 15, 2023 (SPL set 5e1f5e49-2da1-43ab-9795-228a8bcc5a82), via openFDA; the full label on DailyMed

What does the nifedipine label say about doxazosin?

Nifedipine label, drug interactions

Co-administration of nifedipine resulted in a decrease in AUC and C max of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively.

Source: FDA drug label (Nifedipine), Aurobindo Pharma Limited, effective December 24, 2024 (SPL set eb70b7ff-f9f0-41d0-901a-f4c04ae9ed46), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

29Doxazosin generic labelers
32Nifedipine generic labelers
DoxazosinNifedipine
Labeled forEnlarged prostate (BPH), High blood pressureHigh blood pressure, Angina
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0752 per tablet 1 mg tablet$0.130 per tablet 30 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?